SCHEMBL7192108

SCHEMBL7192108

CC(C)Oc1ccc(C(C)(C)C)c(OC(C)C)c1C=CC(=O)c1ccc(N)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
KRAS P01116 1/20 0.44
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CYP1B1 Q16678 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
ABCG2 Q9UNQ0 3/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
NFKB1 P19838 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7192104 1.00 CA1 (0.44) CA1CA2KRASCTSLCTSB
SCHEMBL7187469 0.90 CAPN1 (0.43) CTSLCTSBCYP1B1PDE4APDE4B
SCHEMBL7187460 0.90 CAPN1 (0.43) CTSLCTSBCYP1B1PDE4APDE4B
SCHEMBL7181315 0.89 PTPN1 (0.42) CA1CA2KRASCTSLCTSB
SCHEMBL7181319 0.89 PTPN1 (0.42) CA1CA2KRASCTSLCTSB
SCHEMBL7192538 0.87 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7188038 0.87 PDE4A (0.38) KRASPDE4APDE4BPDE4CPDE4D
SCHEMBL7188035 0.87 PDE4A (0.38) KRASPDE4APDE4BPDE4CPDE4D
SCHEMBL7192535 0.87 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7184488 0.86 CA1 (0.47) CA1CA2KRASCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed